全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

A Multidisciplinary Approach to the Management of Atypical Osseous Epithelioid Hemangioendothelioma

DOI: 10.1155/2014/917425

Full-Text   Cite this paper   Add to My Lib

Abstract:

Hemangioendothelioma is a rare vascular tumor of intermediate malignant potential. Though epithelioid hemangioendothelioma (EH) is commonly found in soft tissues, it has been known to be present in skeletal tissues. The authors present a case of a 50-year-old woman diagnosed with EH of the iliac bone and acetabulum, who experienced pathological fracture at presentation. This report describes a multidisciplinary approach to the management that includes initial incisional biopsy, curettage, and bone grafting, followed by Intensity Modulated Radiation Therapy. The patient finally underwent hemipelvic resection with allograft reconstruction after recurrence. Histopathological study revealed osseous EH of low mitotic activity that stained positively for CD31, CD34, vimentin, and Factor VIII. Herein, the authors discuss the imaging characteristics, histopathological aspects, cytogenetic findings, and the radiobiological behavior of osseous EH. After an aggressive multidisciplinary intervention, the patient is able to achieve local control with no evidence of distal metastatic disease. 1. Introduction Hemangioendothelioma is a rare tumor that exhibits intermediate malignant potential, clinically behaving between benign hemangioma and malignant angiosarcoma. Epithelioid hemangioendothelioma (EH) is the most common histologic subtype that arises from vascular tissue [1] and represents less than one percent of all vascular neoplasms [2]. EH is most commonly found in soft tissues but can also be found in skeletal tissues such as skull, spine, pelvis, femur, and tibia [2]. Primary bone EH accounts for less than one percent of all malignant bone tumors [3]. For certain isolated tumors, curative resection with negative margins can achieve cure and long term local control. Role of chemotherapy and adjuvant radiation therapy remains unclear. Here, we report and discuss the management of epithelioid hemangioendothelioma of the acetabulum and the ilium in the setting of multidisciplinary approach, including orthopedic surgery, radiation oncology, medical oncology, interventional radiology, and pathology. 2. Case Report 2.1. Clinical History 50-year-old African American woman initially presented to the emergency department with a two-week history of vague right hip and lower pelvic pain. Her past medical history was significant for rheumatoid arthritis, diabetes mellitus type 1, and hyperthyroidism status after radioactive iodine ablation. No history of trauma or systemic etiology was found. Physical exam was unremarkable for motor or sensory neurological deficits. No

References

[1]  S. W. Weiss and J. R. Goldblum, “Hemangioendothelioma: vascular tumors of intermediate malignancy,” in Soft Tissue Tumors, F. M. Enzinger and S. W. Weiss, Eds., pp. 891–915, Mosby, St. Louis, Mo, USA, 4th edition.
[2]  http://www.bonetumor.org/unknown-tumor-soft-tissue/epithelioid-hemangioendothelioma.
[3]  H. L. Evans, A. K. Raymond, and A. G. Ayala, “Vascular tumors of bone: a study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma,” Human Pathology, vol. 34, no. 7, pp. 680–689, 2003.
[4]  S. W. Weiss and F. M. Enzinger, “Epitheloid hemangioendothelioma. A vascular tumor often mistaken for a carcinoma,” Cancer, vol. 50, no. 5, pp. 970–981, 1982.
[5]  C. D. Gherman and D. Fodor, “Epithelioid hemangioendothelioma of the forearm with radius involvement. Case report,” Diagnostic Pathology, vol. 6, no. 1, article 120, 2011.
[6]  S. W. Weiss, K. G. Ishak, D. H. Dail, D. E. Sweet, and F. M. Enzinger, “Epithelioid hemangioendothelioma and related lesions,” Seminars in Diagnostic Pathology, vol. 3, no. 4, pp. 259–287, 1986.
[7]  R. D. Boutin, H. J. Spaeth, A. Mangalik, and J. J. Sell, “Epithelioid hemangioendothelioma of bone,” Skeletal Radiology, vol. 25, no. 4, pp. 391–395, 1996.
[8]  G. S. Themistocleous, P. J. Papagelopoulos, K. D. Petraki, E. V. Stillanessi, A. A. Partsinevelos, and G. S. Sapkas, “A 23-year-old woman with complete paraplegia and anesthesia below the T8 level,” Clinical Orthopaedics and Related Research, no. 430, pp. 258–265, 2005.
[9]  R. A. Ibarra, P. Kesava, K. K. Hallet, and C. Bogaev, “Hemangioendothelioma of the temporal bone with radiologic findings resembling hemangioma,” American Journal of Neuroradiology, vol. 22, no. 4, pp. 755–758, 2001.
[10]  P. Thananopavarn, J. K. Smith, and M. Castillo, “MRI of angiosarcoma of the calvaria,” American Journal of Roentgenology, vol. 181, no. 5, pp. 1432–1433, 2003.
[11]  P. Lezama-del Valle, W. L. Gerald, J. Tsai, P. Meyers, and M. P. La Quaglia, “Malignant vascular tumors in young patients,” Cancer, vol. 83, no. 8, pp. 1634–1639, 1998.
[12]  M. Scholsem, D. Raket, P. Flandroy, R. Sciot, and M. Deprez, “Primary temporal bone angiosarcoma: a case report,” Journal of Neuro-Oncology, vol. 75, no. 2, pp. 121–125, 2005.
[13]  M. Tsuji, T. Ozaki, and A. Tsutsumi, “Epithelioid hemangioendothelioma with osteoclast-like giant cells,” Pathology Research and Practice, vol. 198, no. 7, pp. 501–505, 2002.
[14]  K. Aquilina, C. Lim, M. H. Kamel, C. J. Marks, M. G. O'Sullivan, and C. Keohane, “Epithelioid hemangioendothelioma of the spine. Report of two cases,” Journal of Neurosurgery. Spine, vol. 3, no. 5, pp. 393–399, 2005.
[15]  A. Z. Hirsh, W. Yan, L. Wei, A. G. Wernicke, and B. Parashar, “Unresectable retiform hemangioendothelioma treated with external beam radiation therapy and chemotherapy: a case report and review of the literature,” Sarcoma, vol. 2010, Article ID 756246, 3 pages, 2010.
[16]  R. J. Mark, J. C. Poen, L. M. Tran, Y. S. Fu, and G. F. Juillard, “Angiosarcoma: a report of 67 patients and a review of the literature,” Cancer, vol. 77, no. 11, pp. 2400–2406, 1996.
[17]  J. A. Abraham, F. J. Hornicek, A. M. Kaufman et al., “Treatment and outcome of 82 patients with angiosarcoma,” Annals of Surgical Oncology, vol. 14, no. 6, pp. 1953–1967, 2007.
[18]  E. J. Hall and A. J. Giaccia, Radiobiology for the Radiologist, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 7th edition, 2012.
[19]  O. S. Frankfurt, “Mitotic cycle and cell differentiation in squamous cell carcinomas,” International Journal of Cancer, vol. 2, no. 4, pp. 304–310, 1967.
[20]  E. Frindel, E. Malaise, and M. Tubiana, “Cell proliferation kinetics in five human solid tumors,” Cancer, vol. 22, no. 3, pp. 611–620, 1968.
[21]  E. Frindel, et al., “Proliferation kinetics of an experimental ascites tumor of the mouse,” Cell and Tissue Kinetics, vol. 2, pp. 51–65, 1969.
[22]  A. B. Reiskin and R. J. Berry, “Cell proliferation and carcinogenesis in the hamster cheek pouch,” Cancer Research, vol. 28, no. 5, pp. 898–905, 1968.
[23]  A. B. Reiskin and M. L. Mendelsohn, “A comparison of the cell cycle in induced carcinomas and their normal,” Cancer Research, vol. 24, pp. 1131–1136, 1964.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413